Skip to main content
. Author manuscript; available in PMC: 2010 Nov 12.
Published in final edited form as: Stroke. 2004 Mar 4;35(4):998–1004. doi: 10.1161/01.STR.0000119383.76447.05

Figure 2.

Figure 2

Effect of MCAO on microvessel-associated perlecan immunoreactivity compared with laminin. *2P<0.009 (t test) vs laminin at 2-hour ischemia. Ic indicates ischemic core; Ip, region peripheral to the core; and N, normal tissue.